Protagonist Therapeutics PTGX 深 沪
等待开盘 11-06 09:30:00 美东时间
76.70
+0.200
+0.26%
华盛通- 最 高77.44
- 今 开76.50
- 成交量 33.70万股
- 最 低 75.64
- 昨 收 76.50
- 总市值 47.72亿
- 52周最高 93.2499
- 市盈率 静 18.14
- 换手率 0.54%
- 52周最低 33.31
- 委 比 75.96%
- 总股本 6221.13万
- 历史最高 93.2499
- 量 比 0.49
- 振 幅 2.35%
- 历史最低 4.47
- 每 手 1
- 风险率 10.85%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Clearway sets 2030 CAFD per share target of $2.90–$3.10 while expanding growth pathways
Earnings Call Insights: Clearway Energy, Inc. (CWEN.A) Q3 2025 Management View CEO Craig Cornelius announced that "Clearway is well positioned to deliver on its near- and long-term growth objectives a...
11-05 15:37
Comerica declares $0.71 dividend
Comerica (CMA) declares $0.71/share quarterly dividend, in line with previous. Forward yield 3.67% Payable Jan. 1; for shareholders of record Dec. 15; ex-div Dec. 15. See CMA Dividend Scorecard, Yield...
11-05 05:49
美股大行评级 | 上调！苹果、亚马逊、Amkor Tech、Cadence、Confluent、卡特、通用动力等获多家上调目标价
今日重点评级关注：HC Wainwright & Co.：维持PepGen"买入"评级，目标价从12美元升至18美元；Piper Sandler：维持Prothena Corp"超配"评级，目标价从15美元升至36美元
10-29 09:25
Protagonist Therapeutics Announces New Data From Two Studies Of Icotrokinra, Investigational Targeted Oral Peptide That Precisely Blocks IL-23 Receptor
Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing endoscopic improvement
10-27 19:41
美股大行评级 | 潜在最高涨幅37.45%，甲骨文获多家机构上调目标价；瑞穗上调美光科技目标价升至240美元
今日重点评级关注：韦德布什：维持Artiva Biotherapeutics"跑赢大市"评级，目标价从18美元升至23美元；巴克莱：维持Cellectis"超配"评级，目标价从4美元升至8美元
10-20 10:03
Citigroup Maintains Buy on Protagonist Therapeutics, Raises Price Target to $96
Citigroup analyst Geoff Meacham maintains Protagonist Therapeutics (NASDAQ:PTGX) with a Buy and raises the price target from $72 to $96.
10-17 23:29
Bristol Myers Squibb, SystImmune report data from lung cancer trial
Bristol Myers Squibb (NYSE:BMY) and SystImmune reported data from an early-stage study testing their bispecific antibody-drug conjugate, iza-bren, as a treatment for advanced non-small cell lung cance...
10-17 22:40
超40亿美元！强生拟收购Protagonist
（来源：求实药社） 近日，据外媒报道，强生正在洽谈收购其免疫治疗合作伙伴Protagonist Therapeutics(NASDAQ:PTGX)，交易金额预计...
10-17 11:59
Novo Nordisk has reportedly begun U.S. layoffs
Novo Nordisk (NVO) has started a round of job cuts in the U.S. as the weight loss drugmaker continues its plans to eliminate about 9,000 roles globally under a major restructuring drive, Reuters repor...
10-16 00:05
Coinbase parks money in India’s CoinDCX at $2.45B valuation
Cryptocurrency exchange Coinbase Global (NASDAQ:COIN) made a new investment in India’s CoinDCX, valuing the Mumbai-based firm at $2.45 billion post-money. Coinbase said the move reflects its commitm...
10-15 15:05
